Does SECUKINUMAB Cause Therapeutic product effect incomplete? 4,661 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 4,661 reports of Therapeutic product effect incomplete have been filed in association with SECUKINUMAB (COSENTYX). This represents 3.1% of all adverse event reports for SECUKINUMAB.
4,661
Reports of Therapeutic product effect incomplete with SECUKINUMAB
3.1%
of all SECUKINUMAB reports
485
Deaths
798
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From SECUKINUMAB?
Of the 4,661 reports, 485 (10.4%) resulted in death, 798 (17.1%) required hospitalization, and 484 (10.4%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 4,661 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
INFLIXIMAB (3,372)
Which SECUKINUMAB Alternatives Have Lower Therapeutic product effect incomplete Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG